Axon regeneration through scars and into sites of chronic spinal cord injury

Experimental Neurology

Volumn 203, Issue 1, 2007, Pages 8-21

  Lu, Paul ^a,b   Jones, Leonard L ^a,b   Tuszynski, Mark H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Chronic injury; Inhibition; Regeneration; Scar tissue; Spinal cord injury

Indexed keywords

NERVE CELL ADHESION MOLECULE; NEUROTROPHIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BRAIN DAMAGE; CELL SUSPENSION; CERVICAL SPINAL CORD INJURY; CHRONIC DISEASE; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE STIMULATION; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETROVIRUS VECTOR; SCAR FORMATION; SCHWANN CELL; SPINAL CORD INJURY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; ANTIGENS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHRONIC DISEASE; CICATRIX; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; GLIOSIS; GROWTH CONES; GROWTH INHIBITORS; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURAL CELL ADHESION MOLECULE L1; NEURAL CELL ADHESION MOLECULES; NEUROTROPHIN 3; PROTEOGLYCANS; RATS; RATS, INBRED F344; SCHWANN CELLS; SPINAL CORD INJURIES; STROMAL CELLS; TREATMENT OUTCOME;

EID: 33751433363     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.07.030     Document Type: Article

References (74)

1. Ankeny D.P., McTigue D.M., and Jakeman L.B. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp. Neurol. 190 (2004) 17-31
2. Azizi S.A., Stokes D., Augelli B.J., DiGirolamo C., and Prockop D.J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-Similarities to astrocyte grafts. Proc. Natl. Acad. Sci. U. S. A. 95 (1988) 3908-3913
3. Barrett C.P., Donati E.J., and Guth L. Differences between adult and neonatal rats in their astroglial response to spinal injury. Exp. Neurol. 84 (1984) 374-385
4. Blesch A., and Tuszynski M.H. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J. Comp. Neurol. 467 (2003) 403-417
5. Blesch A., Uy H.S., Grill R.J., Cheng J.G., Patterson P.H., and Tuszynski M.H. Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J. Neurosci. 19 (1999) 3556-3566
6. Bradbury E.J., Khemani S., Von R., Priestley King., and McMahon J.V. NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur. J. Neurosci. 11 (1999) 3873-3883
7. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., and McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 (2002) 636-640
8. Braunewell K.H., Pesheva P., McCarthy J.B., Furcht L.T., Schmitz B., and Schachner M. Functional involvement of sciatic nerve-derived versican- and decorin-like molecules and other chondroitin sulphate proteoglycans in ECM-mediated cell adhesion and neurite outgrowth. Eur. J. Neurosci. 7 (1995) 805-814
9. Bunge R.P., Puckett W.R., and Hiester E.D. Observations on the pathology of several types of human spinal cord injury, with emphasis on the astrocyte response to penetrating injuries. Adv. Neurol. 72 (1997) 305-315
10. Conner J.M., and Varon S. Characterization of antibodies to nerve growth factor: assay-dependent variability in the cross-reactivity with other neurotrophins. J. Neurosci. Methods 65 (1996) 93-99
11. Coumans J.V., Lin T.T., Dai H.N., MacArthur L., McAtee M., Nash C., and Bregman B.S. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J. Neurosci. 21 (2001) 9334-9344
12. Davies S.J., Fitch M.T., Memberg S.P., Hall A.K., Raisman G., and Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390 (1997) 680-683
13. Dawson M.R., Levine J.M., and Reynolds R. NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors?. J. Neurosci. Res. 61 (2000) 471-479
14. De Winter F., Oudega M., Lankhorst A.J., Hamers F.P., Blits B., Ruitenberg M.J., Pasterkamp R.J., Gispen W.H., and Verhaagen J. Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp. Neurol. 175 (2002) 61-75
15. Deckner M., Lindholm T., Cullheim S., and Risling M. Differential expression of tenascin-C, tenascin-R, tenascin/J1, and tenascin-X in spinal cord scar tissue and in the olfactory system. Exp. Neurol. 166 (2000) 350-362
16. Dolbeare D., and Houle J.D. Restriction of axonal retraction and promotion of axonal regeneration by chronically injured neurons after intraspinal treatment with glial cell line-derived neurotrophic factor (GDNF). J. Neurotrauma 20 (2003) 1251-1261
17. Dou C.L., and Levine J.M. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14 (1994) 7616-7628
18. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., and Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24 (2004) 2143-2155
19. Fawcett J.W., and Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49 (1999) 377-391
20. Fidler P.S., Schuette K., Asher R.A., Dobbertin A., Thornton S.R., Calle-Patino Y., Muir E., Levine J.M., Geller H.M., Rogers J.H., Faissner A., and Fawcett J.W. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J. Neurosci. 19 (1999) 8778-8788
21. Fitch M.T., and Silver J. Beyond the glial scar. In: Tuszynski M.H., and Kordower J.H. (Eds). CNS Regeneration (1999), Academic Press, San Diego 55-88
22. Frisen J., Haegerstrand A., Risling M., Fried K., Johansson C.B., Hammarberg H., Elde R., Hokfelt T., and Cullheim S. Spinal axons in central nervous system scar tissue are closely related to laminin-immunoreactive astrocytes. Neuroscience 65 (1995) 293-304
23. Grill R., Murai K., Blesch A., Gage F.H., and Tuszynski M.H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 17 (1997) 5560-5572
24. Grill R.J., Blesch A., and Tuszynski M.H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp. Neurol. 148 (1997) 444-452
25. Grimpe B., and Silver J. The extracellular matrix in axon regeneration. Prog. Brain Res. 137 (2002) 333-349
26. Hill C.E., Mood L.D., Wood P.M., and Bunge M.B. Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia 53 (2006) 338-343
27. Hofstetter C.P., Schwarz E.J., Hess D., Widenfalk J., El Manira A., Prockop D.J., and Olson L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2199-2204
28. Houle J.D. Demonstration of the potential for chronically injured neurons to regenerate axons into intraspinal peripheral nerve grafts. Exp. Neurol. 113 (1991) 1-9
29. Houle J.D., and Ye J.H. Survival of chronically-injured neurons can be prolonged by treatment with neurotrophic factors. Neuroscience 94 (1999) 929-936
30. Jin Y., Fischer I., Tessler A., and Houle J.D. Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp. Neurol. 177 (2002) 265-275
31. Jones L.L., and Tuszynski M.H. Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J. Neurosci. 22 (2002) 4611-4624
32. Jones L.L., Sajed D., and Tuszynski M.H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J. Neurosci. 23 (2003) 9276-9288
33. Jones L.L., Margolis R.U., and Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 182 (2003) 399-411
34. Jones L.L., Yamaguchi Y., Stallcup W.B., and Tuszynski M.H. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 22 (2002) 2792-2803
35. Keirstead H.S., Levine J.M., and Blakemore W.F. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22 (1998) 161-170
36. Kinsella T.M., and Nolan G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7 (1996) 1405-1413
37. Kwon B.K., Liu J., Messerer C., Kobayashi N.R., McGraw J., Oschipok L., and Tetzlaff W. Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3246-3251
38. Lemons M.L., Howland D.R., and Anderson D.K. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp. Neurol. 160 (1999) 51-65
39. Levine J.M. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14 (1994) 4716-4730
40. Lu J., Feron F., Mackay-Sim A., and Waite P.M. Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain 125 (2002) 14-21
41. Lu P., Jones L.L., Snyder E.Y., and Tuszynski M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181 (2003) 115-129
42. Lu P., Yang H., Jones L.L., Filbin M.T., and Tuszynski M.H. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci. 24 (2004) 6402-6409
43. Lu P., Jones L.L., and Tuszynski M.H. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp. Neurol. 191 (2005) 344-360
44. McKeon R.J., Jurynec M.J., and Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19 (1999) 10778-10788
45. McMahon S.B., Armanini M.P., Ling L.H., and Phillips H.S. Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 12 (1994) 1161-1171
46. McTigue D.M., Wei P., and Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 21 (2001) 3392-3400
47. Michael G.J., Kaya E., Averill S., Rattray M., Clary D.O., and Priestley J.V. TrkA immunoreactive neurones in the rat spinal cord. J. Comp. Neurol. 385 (1997) 441-455
48. Milev P., Friedlander D.R., Sakurai T., Karthikeyan L., Flad M., Margolis R.K., Grumet M., and Margolis R.U. Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J. Cell Biol. 127 (1994) 1703-1715
49. Miranda J.D., White L.A., Marcillo A.E., Willson C.A., Jagid J., and Whittemore S.R. Induction of Eph B3 after spinal cord injury. Exp. Neurol. 156 (1999) 218-222
50. Moon L.D., Asher R.A., Rhodes K.E., and Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4 (2001) 465-466
51. Moreau-Fauvarque C., Kumanogoh A., Camand E., Jaillard C., Barbin G., Boquet I., Love C., Jones E.Y., Kikutani H., Lubetzki C., Dusart I., and Chedotal A. The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J. Neurosci. 23 (2003) 9229-9239
52. Morgenstern D.A., Asher R.A., and Fawcett J.W. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137 (2002) 313-332
53. Neuhuber B., Timothy Himes B., Shumsky J.S., Gallo G., and Fischer I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibits donor variations. Brain Res. 1035 (2005) 73-85
54. Pasterkamp R.J., Giger R.J., Ruitenberg M.J., Holtmaat A.J., De Wit J., De Winter F., and Verhaagen J. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol. Cell Neurosci. 13 (1999) 143-166
55. Plant G.W., Bates M.L., and Bunge M.B. Inhibitory proteoglycan immunoreactivity is higher at the caudal than the rostral Schwann cell graft-transected spinal cord interface. Mol. Cell Neurosci. 17 (2001) 471-487
56. Qi M.L., Wakabayashi Y., Enomoto M., and Shinomiya K. Changes in neurocan expression in the distal spinal cord stump following complete cord transection: a comparison between infant and adult rats. Neurosci. Res. 45 (2003) 181-188
57. Rodger J., Lindsey K.A., Leaver S.G., King C.E., Dunlop S.A., and Beazley L.D. Expression of ephrin-A2 in the superior colliculus and EphA5 in the retina following optic nerve section in adult rat. Eur. J. Neurosci. 14 (2001) 1929-1936
58. Ruitenberg M.J., Blits B., Dijkhuizen P.A., te Beek E.T., Bakker A., van Heerikhuize J.J., Pool C.W., Hermens W.T., Boer G.J., and Verhaagen J. Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Neurobiol. Dis. 15 (2004) 394-406
59. Schmalfeldt M., Bandtlow C.E., Dours-Zimmermann M.T., Winterhalter K.H., and Zimmermann D.R. Brain derived versican V2 is a potent inhibitor of axonal growth. J. Cell Sci. 113 (2001) 807-816
60. Schnell L., Fearn S., Klassen H., Schwab M.E., and Perry V.H. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 11 (1999) 3648-3658
61. Shumsky J.S., Tobias C.A., Tumolo M., Long W.D., Giszter S.F., and Murray M. Delayed transplantation of fibroblasts genetically modified to secrete BDNF and NT-3 into a spinal cord injury site is associated with limited recovery of function. Exp. Neurol. 184 (2003) 114-130
62. Silver J., and Miller J.H. Regeneration beyond the glial scar. Nat. Rev., Neurosci. 5 (2004) 146-156
63. Storer P.D., and Houle J.D. betaII-tubulin and GAP 43 mRNA expression in chronically injured neurons of the red nucleus after a second spinal cord injury. Exp. Neurol. 183 (2003) 537-547
64. Storer P.D., Dolbeare D., and Houle J.D. Treatment of chronically injured spinal cord with neurotrophic factors stimulates betaII-tubulin and GAP-43 expression in rubrospinal tract neurons. J. Neurosci. Res. 74 (2003) 502-511
65. Tang X., Davies J.E., and Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 71 (2003) 427-444
66. Tobias C.A., Shumsky J.S., Shibata M., Tuszynski M.H., Fischer I., Tessler A., and Murray M. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. 184 (2003) 97-113
67. Tuszynski M.H., Gabriel K., Gage F.H., Suhr S., and Rosetti S. Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury. Exp. Neurol. 137 (1996) 157-173
68. Tuszynski M.H., Grill R., Jones L.L., Brant A., Blesch A., Low K., Lacroix S., and Lu P. NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection. Exp. Neurol. 181 (2003) 47-56
69. Ughrin Y.M., Chen Z.J., and Levine J.M. Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. J. Neurosci. 23 (2003) 175-186
70. Weidner N., Ner A., Salimi N., and Tuszynski M.H. Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3513-3518
71. Wewetzer K., Grothe C., Christ B., and Seilheimer B. Identification and characterization of differentiation-dependent Schwann cell surface antigens by novel monoclonal antibodies: introduction of a marker common to the non-myelin-forming phenotype. Glia 19 (1997) 213-226
72. Woerly S., Doan V.D., Evans-Martin F., Paramore C.G., and Peduzzi J.D. Spinal cord reconstruction using NeuroGel implants and functional recovery after chronic injury. J. Neurosci. Res. 66 (2001) 1187-1197
73. Yamada H., Fredette B., Shitara K., Hagihara K., Miura R., Ranscht B., Stallcup W.B., and Yamaguchi Y. The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons. J. Neurosci. 17 (1997) 7784-7795
74. Ye J.H., and Houle J.D. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp. Neurol. 143 (1997) 70-81